What specific risk factors may necessitate extending anticoagulation treatment beyond 6 months for patients with pulmonary thromboembolism?

Tripdatabase

Open source

DOI
10.5281/zenodo.22251159
Published
2026
Container
Not recorded
Publisher
Zenodo
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5281/zenodo.22251159,
  title = {What specific risk factors may necessitate extending anticoagulation treatment beyond 6 months for patients with pulmonary thromboembolism?},
  author = {Tripdatabase},
  year = {2026},
  doi = {10.5281/zenodo.22251159},
  url = {https://doi.org/10.5281/zenodo.22251159}
}

RIS

TY  - JOUR
TI  - What specific risk factors may necessitate extending anticoagulation treatment beyond 6 months for patients with pulmonary thromboembolism?
AU  - Tripdatabase
PY  - 2026
DO  - 10.5281/zenodo.22251159
UR  - https://doi.org/10.5281/zenodo.22251159
ER  - 

APA

Tripdatabase (2026). What specific risk factors may necessitate extending anticoagulation treatment beyond 6 months for patients with pulmonary thromboembolism?. https://doi.org/10.5281/zenodo.22251159

Source records